lumos-pharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Allow: /wp-admin/admin-ajax.php
Disallow: /wp-admin/

Sitemap: https://lumos-pharma.com/sitemap.xml
Sitemap: https://lumos-pharma.com/sitemap.rss

Meta Tags
Title Lumos Pharma
Description Transforming LivesWithRare Lumos Pharma - Our Focus Is Rare
Keywords pghd,growth deficiency,intellectual disability,mild,severe,language delay,speech deficit,epilepsy,seizures,movement disorders,jerking,clumsiness,delays in crawling,sitting,and walking,behavior disorders,hyperactivity,autism,self-injury
Server Information
WebSite lumos-pharma faviconlumos-pharma.com
Host IP 104.154.74.242
Location United States
Related Websites
Site Rank
More to Explore
lumostransforms.com
lutco.com
lutonheritageforum.org
luxspaceliving.com
luxuranails.com
luxuryhomeswestchester.com
luxurytoothboothinc.squarespace.com
lymebook.com
lynmorton.com
lynnbrownonline.com
lynnfieldgolf.com
lynnlaytonnissan.com
lynnnottage.com
lyonscornerdrug.com
m-pllc.com
m1medical.com
m2oinc.com
m80chicken.com
macbridemuseum.com
maccllc.com
lumos-pharma.com Valuation
US$27,683,468
Last updated: 2022-07-07 10:04:25

lumos-pharma.com has Semrush global rank of 382,333. lumos-pharma.com has an estimated worth of US$ 27,683,468, based on its estimated Ads revenue. lumos-pharma.com receives approximately 3,194,247 unique visitors each day. Its web server is located in United States, with IP address 104.154.74.242. According to SiteAdvisor, lumos-pharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$27,683,468
Daily Ads Revenue US$25,554
Monthly Ads Revenue US$766,620
Yearly Ads Revenue US$9,199,430
Daily Unique Visitors 212,950
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
lumos-pharma.com. A 7199 IP: 104.154.74.242
lumos-pharma.com. NS 7200 NS Record: ns22.worldnic.com.
lumos-pharma.com. NS 7200 NS Record: ns21.worldnic.com.
lumos-pharma.com. MX 3600 MX Record: 10 lumospharma-com01c.mail.protection.outlook.com.
lumos-pharma.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
lumos-pharma.com. TXT 7200 TXT Record: 4nddf997qm0t4p0491zq7w7zqkrnnyj4
lumos-pharma.com. TXT 3600 TXT Record: MS=ms14731991
lumos-pharma.com. TXT 7200 TXT Record: apple-domain-verification=b5PzWuGUmNUVabz7
HtmlToTextCheckTime:2022-07-07 10:04:25
You are using an outdated browser. Please upgrade your browser to improve your experience. --> By continuing to use our site, you agree to our Terms of Use and Privacy Policy . You can learn more about how we use cookies by reviewing our Privacy Policy . I Agree Now enrolling patients in a Phase 2 trial of orally administered LUM-201 for Pediatric Growth Hormone Deficiency Click below to visit ClinicalTrials.gov for more information. LEARN MORE Linkedin Twitter Facebook Instagram Our Company Our Pipeline Resources News Contact --> Company Overview Management Board of Directors Advisory Board Pipeline Overview LUM-201 LUM-201 for PGHD Posters & Publications Partnering Partnering & Collaboration Patients Advocacy & Patients Growth Deficiencies Compassionate Use Clinical Trials Careers Culture Benefits Jobs Investors & Media Investors Press Releases Events & Presentations Posters & Publications Corporate Governance Management Board of Directors Contact the Board Compliance Review
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Fri, 29 Oct 2021 20:49:57 GMT
Content-Type: text/html
Content-Length: 162
Connection: keep-alive
Keep-Alive: timeout=20
Location: https://lumos-pharma.com/

HTTP/2 200 
server: nginx
date: Fri, 29 Oct 2021 20:49:57 GMT
content-type: text/html; charset=UTF-8
content-length: 52976
vary: Accept-Encoding
vary: Accept-Encoding
x-pingback: https://lumos-pharma.com/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 13
x-cache-group: normal
accept-ranges: bytes
lumos-pharma.com Whois Information
Domain Name: LUMOS-PHARMA.COM
Registry Domain ID: 1627882887_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2019-09-22T12:40:18Z
Creation Date: 2010-11-29T19:47:23Z
Registry Expiry Date: 2022-11-29T19:47:23Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS21.WORLDNIC.COM
Name Server: NS22.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T09:01:06Z <<<